fashion -WSS

fashion

author：hotspot 2025-08-26 23:48:05 - browse：24256

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Report: NIH

hotspot

WSS

A pediatrician calls for Congress to pass the child tax credit deal

Medicare drug price lawsuits could be good politics for Biden

HPV vaccine, cervical cancer study delivers historic results

AI used to predict Covid

Medicare bonuses could stop drug shortages under Senate plan

Printout prescription drug information shouldn’t go digital

Wikipedia

fashion

hotspot

Cancer drug shortages should be causing more outrage

Future doctors need a strong humanities education

How to save PrEP access — and even expand it

To bolster infectious disease surveillance, genomics powerhouses team up

Walensky prepares to leave CDC — and Congress — behind

FDA sets aggressive timeline for overhauling inspection procedures

In age of alternative facts, a scholarly course on calling out crap

Akili, maker of video game for ADHD, to be acquired for 34 million

Hollywood unions extend contract negotiations for actors

Childbirth

Wikipedia

Prosthetic arm enables patients to feel the objects they grip

Prior authorization reform is both possible and imperative

Update the Apgar Score to remove skin color

TikTok, Instagram influencers need more rules for drug ads

Heat waves linked to early deliveries, preterm births in new study

Prosthetic arm enables patients to feel the objects they grip

hotspot

focus

hotspot

leisure time